Clinical Trials Browser

Phase 2 × Withdrawn × Biomarkers × Clear all

NCT01070186 2012-07-31

Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma

Phase 2 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms